ACH-1625 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
NEW HAVEN, Conn. -- Achillion Pharmaceuticals, Inc. , a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, announced today the receipt of ...

Cyberonics Announces FDA Approval of Re-Designed AspireHC Generator for VNS Therapy
HOUSTON , Jan. 3, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX - News) today announced that the United States Food and Drug Administration (FDA) has approved its re-designed AspireHC (High Capacity) generator, ...